Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

List of DDDs for 3 years revision

8he DDDs, which will be reviewed at the March 2018 meeting (3 year revision) are listed below. See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2018.

ATC code	ATC level name (INN/generic name)	DDD	Unit	Adm.route

A10BH04	alogliptin	25	mg	O
A10BJ04	albiglutide	5.7	mg	P
A10BJ05	dulaglutide	0.16	mg	P
A10BK02	canagliflozin	0.2	g	O
A10BK03	empagliflozin	17.5	mg	O
A16AX08	teduglutide	5	mg	P
A16AX10	eliglustat	0.168	g	O
C02KX05	riociguat	4.5	mg	O
C09CA09	azilsartan medoxomil	40	mg	O
C10AX12	lomitapide	40	mg	O
G02AD06	misoprostol	0.2	mg	V ¹⁾
J01XB01	colistin	3	MU	Inhal. powder
J05AP05	simeprevir	0.15	g	O
J05AP07	daclatasvir	60	mg	O
J05AP09	dasabuvir	0.5	g	O
L02BX01	abarelix	3.6	mg	P
L03AB13	peginterferon beta-1a	8.9	mcg	P
L04AA29	tofacitinib	10	mg	O
L04AA33	vedolizumab	5.4	mg	P
L04AC11	siltuximab	37	mg	P
N05AH01	loxapine	9.1	mg ²⁾	Inhal. powder
N05AX12	aripiprazole	13.3	mg	P depot
N06BA11	dexmethylphenidate	15	mg	O
N06BA13	armodafinil	0.15	g	O
P01BE03	artesunate	0.28	g	P
R03AC19	olodaterol	5	mcg	Inhal. solution
R03BB07	umeclidinium bromide	55	mcg ³⁾	Inhal. powder
R03CC13	clenbuterol	40	mcg	O
V03AE05	sucroferric oxyhydroxide	1.5	g	O
V03AX03	cobicistat	0.15	g	O

1) vaginal insert, refers to the content of one vaginal insert
2) delivered dose
3) Refers to umeclidinium, delivered dose

Last updated: 2018-01-23